Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in ESPB for Total Hip Arthroplasty
NCT06789042Phase 4Completed
- Sponsor
- Poznan University of Medical Sciences
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in hip osteoarthritis (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoint: Time to first rescue opioid analgesia at 48 hours. Started Feb 2025; status: completed.
02
Drugs
dexamethasone
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NCT06789042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789042.